Actusnews Wire - Professional broadcaster of corporate and regulated information, authorised by the AMF and the CSSF.

  NATUREX company press release from 05/04/2018

  05/04/2018 - 08:00

Appointment of Eight Advisory as independent expert


Company Information

 

Appointment of Eight Advisory as independent expert

 

Press Release
Avignon, 5 April 2018

 

The board of directors of the company appointed as independent expert, Eight Advisory, represented by Alexis Karklins and Geoffroy Bizard, who will be responsible for issuing, pursuant to the provisions of Article 261-1 of the General Regulation of the AMF (French Market Authorities), a report on the financial terms and conditions of the proposed takeover bid that Givaudan could file.

The Board of Directors also appointed an ad hoc committee composed of Daniel Chéron and Anne Abriat to follow the work of the appointed independent expert.

 

 

About Naturex
Naturex sources, manufactures and markets natural speciality ingredients for the food, health and cosmetic industries. As the Natural Maker, the company actively supports the global shift from synthetic to natural through an offer built on two main focus areas: My Natural Food and My Natural Selfcare. Naturex's portfolio includes colours, antioxidants, speciality fruits & vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to create healthy, authentic and effective products.

The Group's strong commitment to quality, sustainability, continuous innovation process, and the talent of its people are at the heart of its success.

Headquartered in Avignon, France, Naturex has experienced steadily-increasing growth throughout the last 25 years. The Group employs 1,700 people worldwide and in 2017 had revenue of €404.9 million.

The Group is listed on Euronext Paris, Compartment B - Index: Euronext Next 150, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa - Ticker: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY
NATUREX, From Nature to You
www.naturex.com

 

  • Investor contact

Carole Alexandre
Head of Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com